Skip to main content
ZS

Zenit Science

This life science company offers a range of contract research services, including cytotoxicity, antimicrobial, and immunohistochemistry testing, alongside advanced imaging and single-cell transcriptomics. They provide comprehensive bioinformatics support to aid drug discovery and scientific research.

Oslo, NorwayFounded 20246200+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Drug discovery and scientific research are often hindered by the need for specialized testing, including cytotoxicity and antimicrobial assessments, advanced imaging, and complex molecular analyses like single-cell transcriptomics and proteomics. These services are often outsourced, requiring researchers to manage multiple vendors and data streams.

Solution

Zenit Science offers a comprehensive suite of contract research services designed to support drug discovery and scientific research. The company provides a range of in vitro assays, including cytotoxicity and antimicrobial testing, to evaluate the safety and efficacy of novel compounds. Zenit Science also offers advanced imaging services, single-cell transcriptomics, proteomics, and bioinformatics support, enabling researchers to gain deeper insights into biological processes and disease mechanisms. By providing a single point of access for a variety of specialized services, Zenit Science streamlines the research process and accelerates scientific breakthroughs.

Target Audience

Zenit Science serves pharmaceutical companies, biotechnology firms, and academic research institutions involved in drug discovery, preclinical research, and translational medicine.

Features

  • Cytotoxicity testing using a standard hemolysis assay to determine the potential harm of compounds to human cell membranes, with customized assays available.
  • Antimicrobial testing to determine the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and kinetics of bactericidal activity against a panel of bacterial strains.
  • Organoid services using 3D cell-based models of human organs for disease modeling, drug screening, and biomarker discovery.
  • Immunohistochemistry (IHC) and high-resolution confocal microscopy for imaging of frozen sections and data analysis.
  • Single-cell transcriptomics using split-pool combinatorial barcoding technology for high-throughput and high-quality single-cell/nuclei transcriptomic profiles.
  • Proteomics services offering accurate protein quantification via global (shotgun) or targeted mass spectrometry.
  • Bioinformatics services for analysis of differentially expressed genes/proteins and pathways affected by gene dysfunction/disease/treatment, including AI-driven omics analysis.
  • Streamlined ordering system for cost-effective standard packages with rapid turnaround times.
This profile is AI-generated and may contain inaccuracies.